Cite
HARVARD Citation
Ibrahim, M. et al. (2023). Theoretical validation of some third-generation epidermal growth factor receptor (EGFR) Inhibitors as non-small cell lung cancer (NSCLC) drugs. Egyptian journal of basic and applied sciences. 10 (1), pp. 329-341. [Online].